Oligomeric amyloid β-protein as a therapeutic target in alzheimer's disease: Its significance based on its distinct localization and the occurrence of a familial variant form

Current Alzheimer Research

Volumn 6, Issue 2, 2009, Pages 132-136

  Ito, Kazuhiro ^a   Ishibashi, Ken Ichi ^a   Tomiyama, Takami ^a   Umeda, Tomohiro ^a   Yamamoto, Kei Ichi ^a   Kitajima, Erika ^a   Idomoto, Toshiki ^a   Nagatomo, Toshie ^a   Mori, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

A ; Alzheimer disease; Amyloid; Oligomer; Recessive hereditary; Synapse

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-42]; GLUTAMIC ACID;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELETION MUTANT; FAMILIAL DISEASE; MOLECULAR MODEL; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

ALANINE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; GLUTAMIC ACID; HUMANS; MICE; MUTATION; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; TEMPORAL LOBE;

EID: 64549128698     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720509787602889     Document Type: Article

References (18)

1. Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, et al. Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 270: 9564-70 (1995).
2. Walsh DM, Klyubin I, Fadeeva JV, Fadeeva JV, Cullen WK, Anwyl R, et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-9 (2002).
3. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-80 (1991).
4. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 298: 789-91 (2002).
5. Lombardo JA, Stern EA, McLellan ME, Kajdasz ST, Hickey GA, Bacskai BJ, et al. Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J Neurosci 23: 10879-883 (2003).
6. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, et al. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25: 7278-287 (2005).
7. 1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-453 (1998).
8. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440: 352-7 (2006).
9. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-06 (1991).
10. Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. A new amyloid β variant favoring oligomeriza-tion in Alzheimer's-type dementia. Ann Neurol 63: 377-87 (2008).
11. Mori H, Takio K, Ogawara M and Selkoe DJ. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem 267: 17082-86 (1992).
12. Lippa CF, Ozawa K, Mann DM, Ishii K, Smith TW, Arawaka S, et al. Deposition of b-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease. Arch Neurol 56: 1111-18 (1999).
13. Ishibashi K, Tomiyama T, Nishitsuji K, Hara M, and Mori H. Absence of synaptophysin near cortical neurons containing oligomer Aβ in Alzheimer's disease brain. J Neurosci Res 84: 632-6 (2006).
14. Walsh DM, Tseng BP, Rydel RE, Podlisny MB and Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39: 10831-39 (2000).
15. Kayed R, Head E, Thompson JL, Mclntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-9 (2003).
16. Matsuyama S, Tomiyama T, Teraoka R and Mori H. Inverse correlation between APP and synaptic plasticity in transgenic mice. Neuroreport 18: 1083-7 (2007).
17. Takuma H, Teraoka R, Mori H and Tomiyama T. Amyloid-β E22A variant induces synaptic alteration in mouse hippocampal slices. Neuroreport 19: 615-19 (2008).
18. Schmechel A, Zentgraf H, Scheuermann S, Fritz G, Pipkorn R, Reed J, et al. Alzheimer β-amyloid homodimers facilitate Aβ Fibrillization and the generation of conformational antibodies. J Biol Chem 278: 35317-35324 (2003).